Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death), hospital utilization, and medical expenditure in Greece during the period 1995-2010. The estimates indicate that … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)-—about 44% of the total increase in longevity …

probability of receiving public ambulatory care by 2.7 ppt (5%) and of admission to a public hospital by 1 ppt (18%). OOP …

that the connection between overconfidence and innovation is more complex than the previous literature suggests. In … innovative activity. While overoptimism leads to an innovation enhancing effect, judgmental overconfidence inhibits innovation …. Our results indicate that future research is well advised to take into account that the relationship between innovation …

We study innovation contests with asymmetric information and identical contestants, where contestants’ efforts and … highest quality and receives the revenue generated by the innovation. We characterize the equilibrium behavior, outcomes and …

We develop a theory of innovation for entry and sale into oligopoly, and show that inventions of higher quality are …

destructive part of creative destruction is a social cost and therefore biases our estimate of the impact of the innovation on NNP …

Substantial elements of innovation have been observable during recent years in rig supply, in particular regarding …